MediciNova Inc
NASDAQ:MNOV
MediciNova Inc
Interest Income Expense
MediciNova Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MediciNova Inc
NASDAQ:MNOV
|
Interest Income Expense
$1.8m
|
CAGR 3-Years
72%
|
CAGR 5-Years
14%
|
CAGR 10-Years
68%
|
|
Abbvie Inc
NYSE:ABBV
|
Interest Income Expense
-$1.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-19%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Interest Income Expense
-$757m
|
CAGR 3-Years
35%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-10%
|
|
Amgen Inc
NASDAQ:AMGN
|
Interest Income Expense
-$2.9B
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-16%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Interest Income Expense
$563.1m
|
CAGR 3-Years
78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Interest Income Expense
$221.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
See Also
What is MediciNova Inc's Interest Income Expense?
Interest Income Expense
1.8m
USD
Based on the financial report for Dec 31, 2023, MediciNova Inc's Interest Income Expense amounts to 1.8m USD.
What is MediciNova Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
68%
Over the last year, the Interest Income Expense growth was 127%. The average annual Interest Income Expense growth rates for MediciNova Inc have been 72% over the past three years , 14% over the past five years , and 68% over the past ten years .